Stay updated on Dose Determination and Efficacy of Vesleteplirsen Clinical Trial

Sign up to get notified when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, and the earlier operating-status notice related to funding has been removed; these changes are limited to site-wide notices and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:56:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's status has been added, with links to cc.nih.gov and opm.gov for updates. The page version was updated to Revision: v3.4.1, replacing v3.4.0—To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:39:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI and metadata updates were made, including a glossary toggle and revised QC-related fields and revision number. These changes do not alter core study content, eligibility criteria, or primary outcomes.
    Difference
    0.2%
    Check dated 2026-01-28T02:39:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.3.4 and removed Revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:34:36.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added comprehensive Locations sections listing sites in California, Connecticut, Florida, Georgia, Iowa, Kansas, Massachusetts, Pennsylvania, Texas, Washington, Ontario, and Lancashire, with an update to revision v3.3.3. The HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-23T12:36:08.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.1 to v3.3.2, which appears to be an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:49.000Z thumbnail image

Stay in the know with updates to Dose Determination and Efficacy of Vesleteplirsen Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Determination and Efficacy of Vesleteplirsen Clinical Trial page.